Stock GENX GENIX PHARMACEUTICALS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Genix Pharmaceuticals Corporation

Equities

GENX

CA37232A1093

Food Processing

Market Closed - Toronto S.E.
Other stock markets
 11:14:16 09/05/2024 pm IST 		5-day change 1st Jan Change
0.05 CAD +11.11% Intraday chart for Genix Pharmaceuticals Corporation +25.00% +150.00%
26/03 Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended January 31, 2024 CI
28/02 Genix Pharmaceuticals Corporation Reports Earnings Results for the Full Year Ended October 31, 2023 CI

Valuation

Fiscal Period: Oktober 2018 2019 2020 2021 2022 2023
Capitalization 1 2.438 2.626 9.803 8.884 3.85 2.369
Enterprise Value (EV) 1 2.369 2.615 9.121 8.794 4.023 2.869
P/E ratio 18.2 x -15.9 x -11.5 x -5.38 x -3.58 x -0.54 x
Yield - - - - - -
Capitalization / Revenue 5.81 x 19.1 x - - - 192 x
EV / Revenue 5.64 x 19 x - - - 232 x
EV / EBITDA -100 x -21.3 x -28.9 x -8.05 x -8.82 x -9.92 x
EV / FCF -15.5 x 91.6 x 31.7 x 13 x 23.4 x 47.6 x
FCF Yield -6.45% 1.09% 3.16% 7.7% 4.28% 2.1%
Price to Book 19.9 x -62.3 x 2.01 x 2.21 x 1.2 x -2.08 x
Nbr of stocks (in thousands) 37,514 37,514 59,409 59,224 59,224 59,224
Reference price 2 0.0650 0.0700 0.1650 0.1500 0.0650 0.0400
Announcement Date 01/03/19 27/02/20 01/03/21 28/02/22 28/02/23 27/02/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Oktober 2018 2019 2020 2021 2022 2023
Net sales 1 0.42 0.1374 - - - 0.0123
EBITDA 1 -0.0236 -0.123 -0.3156 -1.092 -0.4559 -0.2893
EBIT 1 -0.0237 -0.1232 -0.6767 -1.615 -0.9984 -0.8318
Operating Margin -5.64% -89.67% - - - -6,737.05%
Earnings before Tax (EBT) 1 -0.0252 -0.1647 -0.7187 -1.653 -1.074 -4.396
Net income 1 0.1341 -0.1647 -0.7187 -1.653 -1.074 -4.396
Net margin 31.92% -119.87% - - - -35,600.34%
EPS 2 0.003573 -0.004390 -0.0144 -0.0279 -0.0181 -0.0742
Free Cash Flow 1 -0.1527 0.0286 0.2881 0.6769 0.172 0.0603
FCF margin -36.35% 20.79% - - - 488.3%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 01/03/19 27/02/20 01/03/21 28/02/22 28/02/23 27/02/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: October 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 0.17 0.5
Net Cash position 1 0.07 0.01 0.68 0.09 - -
Leverage (Debt/EBITDA) - - - - -0.38 x -1.728 x
Free Cash Flow 1 -0.15 0.03 0.29 0.68 0.17 0.06
ROE (net income / shareholders' equity) -20.7% -410% -29.8% -37.3% -29.8% -426%
ROA (Net income/ Total Assets) -4.73% -56.6% -15.7% -20% -13.8% -23.2%
Assets 1 -2.832 0.2909 4.577 8.283 7.764 18.92
Book Value Per Share 2 0 -0 0.0800 0.0700 0.0500 -0.0200
Cash Flow per Share 2 0 0 0.0100 0 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 01/03/19 27/02/20 01/03/21 28/02/22 28/02/23 27/02/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
GENIX PHARMACEUTICALS CORPORATION Stock Genix Pharmaceuticals Corporation
+150.00% 2.17M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+16.80% 8.43B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+15.02% 6.82B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-4.77% 3.77B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-6.75% 3.74B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
+4.41% 1.44B
HERBALIFE LTD. Stock Herbalife Ltd.
-30.34% 1.06B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+20.28% 1.04B
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-12.85% 890M
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-15.63% 812M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. GENX Stock
  4. Financials Genix Pharmaceuticals Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW